Literature DB >> 3185289

Resting energy expenditure in lung and colon cancer.

D W Nixon1, M Kutner, S Heymsfield, A T Foltz, C Carty, S Seitz, K Casper, W K Evans, K N Jeejeebhoy, J M Daly.   

Abstract

Elevated resting energy expenditure (REE) is a possible mechanism of cancer cachexia. We measured REE by whole-body direct calorimetry in patients with colon and non-small cell lung cancer and compared the results with REE in groups of healthy subjects and in patients with anorexia nervosa, with nonmalignant gastrointestinal (GI) disease, with miscellaneous reasons for weight loss, and with chronic lung disease. The mean REE of the cancer patients was not different from healthy subjects, those with GI disease, miscellaneous causes of cachexia, and chronic lung disease, and there was no significant difference in REE between those cancer patients with weight loss and controls with weight loss, except for the anorexia nervosa patients. The REE of the anorexia nervosa patients (female) was significantly lower than the REE of females with lung cancer. Weight loss correlated with REE in female lung cancer patients. Serial comparison of REE of ten cancer patients who lost 5% to 18% of their body weight during study showed no consistent change in REE. We conclude that patients with colon and non-small cell lung cancer, including those with weight loss, have REE similar to normal controls. Relative hypermetabolism may contribute to cancer cachexia, as may absolute hypermetabolism in some subsets of cancer patients.

Entities:  

Mesh:

Year:  1988        PMID: 3185289     DOI: 10.1016/0026-0495(88)90068-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.

Authors:  Sarah A Purcell; Sarah A Elliott; Peter J Walter; Tom Preston; Hongyi Cai; Richard J E Skipworth; Michael B Sawyer; Carla M Prado
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

2.  Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.

Authors:  Jane A Read; Philip J Beale; Dianne H Volker; Narelle Smith; Annabel Childs; Stephen J Clarke
Journal:  Support Care Cancer       Date:  2006-10-05       Impact factor: 3.603

3.  Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer.

Authors:  Andre Lima Queiroz; Ezequiel Dantas; Shakti Ramsamooj; Anirudh Murthy; Mujmmail Ahmed; Elizabeth R M Zunica; Roger J Liang; Jessica Murphy; Corey D Holman; Curtis J Bare; Gregory Ghahramani; Zhidan Wu; David E Cohen; John P Kirwan; Lewis C Cantley; Christopher L Axelrod; Marcus D Goncalves
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

Review 4.  Diet and nutrition in cancer survivorship and palliative care.

Authors:  Anthony J Bazzan; Andrew B Newberg; William C Cho; Daniel A Monti
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.